Royalty Pharma raises 2026 guidance after 14% Royalty Receipts growth in Q2Aug 5Quarterly updateRoyalty Pharma plc
GSK wins US approval for Jideytro in previously treated ROS1-positive lung cancerJul 22Regulatory decisionGlaxoSmithKlinezidesamtinib
Sign inSign in